Taylor Morrison Home Corporation
Taylor Morrison Home Corporation (TMHC) Stock Competitors & Peer Comparison
See (TMHC) competitors and their performances in Stock Market.
Peer Comparison Table: Residential Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| TMHC | $60.59 | -0.26% | 6B | 7.01 | $8.65 | N/A |
| DHI | $146.20 | +0.61% | 43.6B | 11.76 | $12.44 | +1.03% |
| LEN-B | $111.75 | +0.83% | 30B | 9.26 | $12.07 | +1.73% |
| LEN | $116.14 | +0.70% | 29.9B | 9.61 | $12.08 | +1.73% |
| PHM | $116.82 | +0.40% | 23.1B | 8.75 | $13.36 | +0.74% |
| NVR | $7,845.30 | +0.67% | 23B | 16.60 | $473.03 | N/A |
| TOL | $123.32 | +0.23% | 12.1B | 9.17 | $13.45 | +0.78% |
| MTH | $70.37 | +0.86% | 5.1B | 8.02 | $8.77 | +2.30% |
| MDC | $62.98 | +0.05% | 4.7B | 11.91 | $5.29 | N/A |
| KBH | $57.03 | +0.30% | 3.9B | 7.56 | $7.54 | +1.77% |
Stock Comparison
TMHC vs DHI Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, DHI has a market cap of 43.6B. Regarding current trading prices, TMHC is priced at $60.59, while DHI trades at $146.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas DHI's P/E ratio is 11.76. In terms of profitability, TMHC's ROE is +0.15%, compared to DHI's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to DHI. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check DHI's competition here
TMHC vs LEN-B Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, LEN-B has a market cap of 30B. Regarding current trading prices, TMHC is priced at $60.59, while LEN-B trades at $111.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas LEN-B's P/E ratio is 9.26. In terms of profitability, TMHC's ROE is +0.15%, compared to LEN-B's ROE of +0.16%. Regarding short-term risk, TMHC is more volatile compared to LEN-B. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check LEN-B's competition here
TMHC vs LEN Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, LEN has a market cap of 29.9B. Regarding current trading prices, TMHC is priced at $60.59, while LEN trades at $116.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas LEN's P/E ratio is 9.61. In terms of profitability, TMHC's ROE is +0.15%, compared to LEN's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to LEN. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LEN's competition here
TMHC vs PHM Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, PHM has a market cap of 23.1B. Regarding current trading prices, TMHC is priced at $60.59, while PHM trades at $116.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas PHM's P/E ratio is 8.75. In terms of profitability, TMHC's ROE is +0.15%, compared to PHM's ROE of +0.18%. Regarding short-term risk, TMHC is less volatile compared to PHM. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check PHM's competition here
TMHC vs NVR Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, NVR has a market cap of 23B. Regarding current trading prices, TMHC is priced at $60.59, while NVR trades at $7,845.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas NVR's P/E ratio is 16.60. In terms of profitability, TMHC's ROE is +0.15%, compared to NVR's ROE of +0.48%. Regarding short-term risk, TMHC is less volatile compared to NVR. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check NVR's competition here
TMHC vs TOL Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, TOL has a market cap of 12.1B. Regarding current trading prices, TMHC is priced at $60.59, while TOL trades at $123.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas TOL's P/E ratio is 9.17. In terms of profitability, TMHC's ROE is +0.15%, compared to TOL's ROE of +0.18%. Regarding short-term risk, TMHC is less volatile compared to TOL. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check TOL's competition here
TMHC vs MTH Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, MTH has a market cap of 5.1B. Regarding current trading prices, TMHC is priced at $60.59, while MTH trades at $70.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas MTH's P/E ratio is 8.02. In terms of profitability, TMHC's ROE is +0.15%, compared to MTH's ROE of +0.16%. Regarding short-term risk, TMHC is less volatile compared to MTH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check MTH's competition here
TMHC vs MDC Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, MDC has a market cap of 4.7B. Regarding current trading prices, TMHC is priced at $60.59, while MDC trades at $62.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas MDC's P/E ratio is 11.91. In terms of profitability, TMHC's ROE is +0.15%, compared to MDC's ROE of +0.11%. Regarding short-term risk, TMHC is more volatile compared to MDC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check MDC's competition here
TMHC vs KBH Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, KBH has a market cap of 3.9B. Regarding current trading prices, TMHC is priced at $60.59, while KBH trades at $57.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas KBH's P/E ratio is 7.56. In terms of profitability, TMHC's ROE is +0.15%, compared to KBH's ROE of +0.14%. Regarding short-term risk, TMHC is less volatile compared to KBH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check KBH's competition here
TMHC vs SKY Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, SKY has a market cap of 3.7B. Regarding current trading prices, TMHC is priced at $60.59, while SKY trades at $65.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas SKY's P/E ratio is 19.03. In terms of profitability, TMHC's ROE is +0.15%, compared to SKY's ROE of +0.13%. Regarding short-term risk, TMHC is more volatile compared to SKY. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check SKY's competition here
TMHC vs CVCO Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, CVCO has a market cap of 3.4B. Regarding current trading prices, TMHC is priced at $60.59, while CVCO trades at $414.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas CVCO's P/E ratio is 20.02. In terms of profitability, TMHC's ROE is +0.15%, compared to CVCO's ROE of +0.17%. Regarding short-term risk, TMHC is less volatile compared to CVCO. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check CVCO's competition here
TMHC vs MHO Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, MHO has a market cap of 3.3B. Regarding current trading prices, TMHC is priced at $60.59, while MHO trades at $123.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas MHO's P/E ratio is 6.78. In terms of profitability, TMHC's ROE is +0.15%, compared to MHO's ROE of +0.15%. Regarding short-term risk, TMHC is less volatile compared to MHO. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check MHO's competition here
TMHC vs GRBK Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, GRBK has a market cap of 2.9B. Regarding current trading prices, TMHC is priced at $60.59, while GRBK trades at $66.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas GRBK's P/E ratio is 8.05. In terms of profitability, TMHC's ROE is +0.15%, compared to GRBK's ROE of +0.24%. Regarding short-term risk, TMHC is less volatile compared to GRBK. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check GRBK's competition here
TMHC vs TPH Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, TPH has a market cap of 2.8B. Regarding current trading prices, TMHC is priced at $60.59, while TPH trades at $31.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas TPH's P/E ratio is 8.06. In terms of profitability, TMHC's ROE is +0.15%, compared to TPH's ROE of +0.11%. Regarding short-term risk, TMHC is less volatile compared to TPH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check TPH's competition here
TMHC vs DFH Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, DFH has a market cap of 2.6B. Regarding current trading prices, TMHC is priced at $60.59, while DFH trades at $27.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas DFH's P/E ratio is 8.22. In terms of profitability, TMHC's ROE is +0.15%, compared to DFH's ROE of +0.25%. Regarding short-term risk, TMHC is less volatile compared to DFH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check DFH's competition here
TMHC vs CCS Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, CCS has a market cap of 1.8B. Regarding current trading prices, TMHC is priced at $60.59, while CCS trades at $59.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas CCS's P/E ratio is 7.21. In terms of profitability, TMHC's ROE is +0.15%, compared to CCS's ROE of +0.10%. Regarding short-term risk, TMHC is less volatile compared to CCS. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check CCS's competition here
TMHC vs LGIH Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, LGIH has a market cap of 1.3B. Regarding current trading prices, TMHC is priced at $60.59, while LGIH trades at $56.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas LGIH's P/E ratio is 7.34. In terms of profitability, TMHC's ROE is +0.15%, compared to LGIH's ROE of +0.09%. Regarding short-term risk, TMHC is less volatile compared to LGIH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check LGIH's competition here
TMHC vs GRBK-PA Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, GRBK-PA has a market cap of 1.1B. Regarding current trading prices, TMHC is priced at $60.59, while GRBK-PA trades at $24.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas GRBK-PA's P/E ratio is 5.45. In terms of profitability, TMHC's ROE is +0.15%, compared to GRBK-PA's ROE of +0.24%. Regarding short-term risk, TMHC is more volatile compared to GRBK-PA. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check GRBK-PA's competition here
TMHC vs BZH Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, BZH has a market cap of 746.1M. Regarding current trading prices, TMHC is priced at $60.59, while BZH trades at $24.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas BZH's P/E ratio is 7.97. In terms of profitability, TMHC's ROE is +0.15%, compared to BZH's ROE of +0.08%. Regarding short-term risk, TMHC is less volatile compared to BZH. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check BZH's competition here
TMHC vs HOVNP Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, HOVNP has a market cap of 678.9M. Regarding current trading prices, TMHC is priced at $60.59, while HOVNP trades at $19.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas HOVNP's P/E ratio is -7.84. In terms of profitability, TMHC's ROE is +0.15%, compared to HOVNP's ROE of +0.27%. Regarding short-term risk, TMHC is less volatile compared to HOVNP. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check HOVNP's competition here
TMHC vs HOV Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, HOV has a market cap of 617.7M. Regarding current trading prices, TMHC is priced at $60.59, while HOV trades at $121.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas HOV's P/E ratio is 4.32. In terms of profitability, TMHC's ROE is +0.15%, compared to HOV's ROE of +0.27%. Regarding short-term risk, TMHC is less volatile compared to HOV. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check HOV's competition here
TMHC vs LEGH Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, LEGH has a market cap of 548.4M. Regarding current trading prices, TMHC is priced at $60.59, while LEGH trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas LEGH's P/E ratio is 9.93. In terms of profitability, TMHC's ROE is +0.15%, compared to LEGH's ROE of +0.12%. Regarding short-term risk, TMHC is more volatile compared to LEGH. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check LEGH's competition here
TMHC vs SIC Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, SIC has a market cap of 376M. Regarding current trading prices, TMHC is priced at $60.59, while SIC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas SIC's P/E ratio is 7.11. In terms of profitability, TMHC's ROE is +0.15%, compared to SIC's ROE of -0.06%. Regarding short-term risk, TMHC is more volatile compared to SIC. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check SIC's competition here
TMHC vs UHG Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, UHG has a market cap of 237.9M. Regarding current trading prices, TMHC is priced at $60.59, while UHG trades at $4.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas UHG's P/E ratio is 5.41. In terms of profitability, TMHC's ROE is +0.15%, compared to UHG's ROE of +0.80%. Regarding short-term risk, TMHC is less volatile compared to UHG. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check UHG's competition here
TMHC vs SPHL Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, SPHL has a market cap of 6.2M. Regarding current trading prices, TMHC is priced at $60.59, while SPHL trades at $0.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas SPHL's P/E ratio is -13.50. In terms of profitability, TMHC's ROE is +0.15%, compared to SPHL's ROE of -0.18%. Regarding short-term risk, TMHC is less volatile compared to SPHL. This indicates potentially lower risk in terms of short-term price fluctuations for TMHC.Check SPHL's competition here
TMHC vs NWHM Comparison July 2025
TMHC plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, TMHC stands at 6B. In comparison, NWHM has a market cap of 0. Regarding current trading prices, TMHC is priced at $60.59, while NWHM trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
TMHC currently has a P/E ratio of 7.01, whereas NWHM's P/E ratio is N/A. In terms of profitability, TMHC's ROE is +0.15%, compared to NWHM's ROE of -0.15%. Regarding short-term risk, TMHC is more volatile compared to NWHM. This indicates potentially higher risk in terms of short-term price fluctuations for TMHC.Check NWHM's competition here